Literature DB >> 16513206

Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer.

Lisa Simi1, Giulia Venturini, Francesca Malentacchi, Stefania Gelmini, Matteo Andreani, Alberto Janni, Silvia Pastorekova, Claudiu T Supuran, Mario Pazzagli, Claudio Orlando.   

Abstract

Hypoxia is associated with malignant progression and poor outcome in human cancers. The effects of hypoxia are mediated by a series of genomic changes that enable tumor cells to survive or escape their oxygen deficient environment. Recent studies indicated that carbonic anhydrase IX (CA IX) is an intrinsic marker of hypoxia. In the present study we investigated with quantitative RT-PCR the expression of CA IX mRNA in 93 non-small cell lung carcinomas (NSCLC) and in their paired not affected tissues. CA IX mRNA was expressed in 100% NSCLC and in 76% of paired not affected tissues, even if tumoral CA IX expression was found constantly higher (p < 0.02) than that found in normal tissues. The increase of CA IX mRNA expression in cancer tissues was significantly correlated to the increase of corresponding protein, as determined with conventional immunoblotting (p = 0.027). In addition the expression of CA IX mRNA in NSCLC samples was significantly correlated to VEGF (p = 0.002) and MMP-9 (p = 0.002) mRNAs. Whereas CA IX mRNA expression was not associated to any clinical-pathological parameters in our patients, global survival analysis of cancer-related death revealed that high expression of CA IX mRNA predicted unfavorable outcome (p = 0.001) and shorter disease free survival interval (p = 0.004). A multivariate analysis showed that CA IX expression was the strongest prognostic parameter (p = 0.000) in comparison to other conventional predictive markers. In addition, differences emerged on the basis of clinical-pathological parameters: in fact separate Kaplan-Meyer analyses of patients indicated that whereas high levels of CA IX mRNA expression were not predictive of worse prognosis in early NSCLC (G1, T1, Stage 1 and pN- patients), this parameter appeared highly significant in advanced NSCLC (G2-G3, T2-T3, Stage 2-3 and pN+ patients). Finally we demonstrated that CA IX expression was not able to discriminate different survival probability in adenocarcinomas, whereas the same parameter was highly predictive in squamous (p = 0.03) and adenosquamous cell carcinomas (p = 0.001).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513206     DOI: 10.1016/j.lungcan.2005.11.017

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  12 in total

Review 1.  The tumor microenvironment in non-small-cell lung cancer.

Authors:  Edward E Graves; Amit Maity; Quynh-Thu Le
Journal:  Semin Radiat Oncol       Date:  2010-07       Impact factor: 5.934

2.  High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer.

Authors:  M Ilie; N M Mazure; V Hofman; R E Ammadi; C Ortholan; C Bonnetaud; K Havet; N Venissac; B Mograbi; J Mouroux; J Pouysségur; P Hofman
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

3.  Roles of Carbonic Anhydrase IX in Development of Pancreatic Cancer.

Authors:  Yuji Li; Ming Dong; Weiwei Sheng; Longping Huang
Journal:  Pathol Oncol Res       Date:  2015-07-30       Impact factor: 3.201

4.  Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer.

Authors:  David J Stewart; Maria I Nunez; Carmen Behrens; Diane Liu; Yan Heather Lin; J Jack Lee; Jack Roth; John Heymach; Stephen G Swisher; Waun Ki Hong; Ignacio Ivan Wistuba
Journal:  J Thorac Oncol       Date:  2014-05       Impact factor: 15.609

5.  Non-coding RNAs predict recurrence-free survival of patients with hypoxic tumours.

Authors:  Victor D Martinez; Natalie S Firmino; Erin A Marshall; Kevin W Ng; Brennan J Wadsworth; Christine Anderson; Wan L Lam; Kevin L Bennewith
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

6.  A voting approach to identify a small number of highly predictive genes using multiple classifiers.

Authors:  Md Rafiul Hassan; M Maruf Hossain; James Bailey; Geoff Macintyre; Joshua W K Ho; Kotagiri Ramamohanarao
Journal:  BMC Bioinformatics       Date:  2009-01-30       Impact factor: 3.169

7.  Carbonic anhydrase IX is a critical determinant of pulmonary microvascular endothelial cell pH regulation and angiogenesis during acidosis.

Authors:  Ji Young Lee; Mikhail Alexeyev; Natalya Kozhukhar; Viktoriya Pastukh; Roderica White; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-04-05       Impact factor: 5.464

8.  Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer.

Authors:  E Korkeila; K Talvinen; P M Jaakkola; H Minn; K Syrjänen; J Sundström; S Pyrhönen
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

9.  Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma.

Authors:  N Tanaka; H Kato; T Inose; H Kimura; A Faried; M Sohda; M Nakajima; Y Fukai; T Miyazaki; N Masuda; M Fukuchi; H Kuwano
Journal:  Br J Cancer       Date:  2008-10-07       Impact factor: 7.640

10.  Cell-surface marker discovery for lung cancer.

Authors:  Allison S Cohen; Farah K Khalil; Eric A Welsh; Matthew B Schabath; Steven A Enkemann; Andrea Davis; Jun-Min Zhou; David C Boulware; Jongphil Kim; Eric B Haura; David L Morse
Journal:  Oncotarget       Date:  2017-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.